Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
6,640.00
-10.00 (-0.15%)
At close: May 29, 2026
KOSDAQ:036480 Revenue
Daesung Microbiological Labs. had revenue of 5.08B KRW in the quarter ending March 31, 2026, a decrease of -2.29%. This brings the company's revenue in the last twelve months to 25.87B, up 10.50% year-over-year. In the year 2025, Daesung Microbiological Labs. had annual revenue of 25.99B with 9.18% growth.
Revenue (ttm)
25.87B
Revenue Growth
+10.50%
P/S Ratio
0.98
Revenue / Employee
193.06M
Employees
134
Market Cap
25.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 25.99B | 2.18B | 9.18% |
| Dec 31, 2024 | 23.80B | -1.76B | -6.88% |
| Dec 31, 2023 | 25.56B | 62.26M | 0.24% |
| Dec 31, 2022 | 25.50B | 1.50B | 6.26% |
| Dec 31, 2021 | 24.00B | -803.74M | -3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hurum | 99.01B |
| GeneBioTech Co. ,Ltd | 89.44B |
| ChoA Pharmaceutical Co., LTD. | 59.62B |
| Kyung Nam Pharm | 56.18B |
| Seoul Pharma | 51.33B |
| Kwangdong Healthbio | 38.10B |
| Union Korea Pharm | 29.66B |
| BIFIDO | 17.23B |